Andrew's Notes

p53 loss is common but not enriched in chromosomally unstable tumors

2 min read

While p53 inactivation is a frequent event across many tumor types, it is not specifically enriched in chromosomally unstable tumors and does not represent the preferential genetic pathway for CIN tumors to acquire malignancy. This contrasts with the selective pressure for Stat1 inactivation combined with Myc activation in aneuploid tumors. [@schubert_cancer_2021]

Definitions

Synthesis

While p53 inactivation is a frequent event in cancer, it is not specifically enriched in chromosomally unstable tumors, distinguishing it from other genetic alterations that appear to be selected for in the context of chromosomal instability. This contrasts with Stat1 inactivation and Myc activation, which are specifically enriched in chromosomally unstable tumors and work together to suppress the immune cell infiltration that chromosomal instability normally provokes. The differential enrichment patterns suggest that whereas p53 loss provides general oncogenic advantages across diverse tumor types, the Stat1-Myc alteration represents a specialized adaptive solution to the unique fitness cost imposed by chromosomal instability—namely, increased immune surveillance. What remains unresolved is why chromosomally unstable tumors do not show preferential selection for p53 loss despite its well-established role in maintaining genomic stability and its common occurrence across cancers.

Bibliography

Graph View

Backlinks